What is a stock summary page? Click here for an overview.
Current and historical daily PE Ratio for MEDGF (
Medacta Group
) from 2019 to Apr 28 2025. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Medacta Group stock (MEDGF) PE ratio as of Apr 28 2025 is 37.95.
More Details
Medacta Group SA (MEDGF) PE Ratio (TTM) Chart
Medacta Group SA (MEDGF) PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Total 1212
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Medacta Group PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2025-04-28 | 21.6 | 2025-02-21 | 21.6 |
2025-04-25 | 21.6 | 2025-02-20 | 21.6 |
2025-04-24 | 21.6 | 2025-02-19 | 21.6 |
2025-04-23 | 21.6 | 2025-02-18 | 21.6 |
2025-04-22 | 21.6 | 2025-02-14 | 21.6 |
2025-04-21 | 21.6 | 2025-02-13 | 21.6 |
2025-04-17 | 21.6 | 2025-02-12 | 21.6 |
2025-04-16 | 21.6 | 2025-02-11 | 21.6 |
2025-04-15 | 21.6 | 2025-02-10 | 21.6 |
2025-04-14 | 21.6 | 2025-02-07 | 21.6 |
2025-04-11 | 21.6 | 2025-02-06 | 21.6 |
2025-04-10 | 21.6 | 2025-02-05 | 21.6 |
2025-04-09 | 21.6 | 2025-02-04 | 21.6 |
2025-04-08 | 21.6 | 2025-02-03 | 21.6 |
2025-04-07 | 21.6 | 2025-01-31 | 21.6 |
2025-04-04 | 21.6 | 2025-01-30 | 21.6 |
2025-04-03 | 21.6 | 2025-01-29 | 21.6 |
2025-04-02 | 21.6 | 2025-01-28 | 21.6 |
2025-04-01 | 21.6 | 2025-01-27 | 21.6 |
2025-03-31 | 21.6 | 2025-01-24 | 21.6 |
2025-03-28 | 21.6 | 2025-01-23 | 21.6 |
2025-03-27 | 21.6 | 2025-01-22 | 21.6 |
2025-03-26 | 21.6 | 2025-01-21 | 21.6 |
2025-03-25 | 21.6 | 2025-01-17 | 21.6 |
2025-03-24 | 21.6 | 2025-01-16 | 21.6 |
2025-03-21 | 21.6 | 2025-01-15 | 21.6 |
2025-03-20 | 21.6 | 2025-01-14 | 21.6 |
2025-03-19 | 21.6 | 2025-01-13 | 21.6 |
2025-03-18 | 21.6 | 2025-01-10 | 21.6 |
2025-03-17 | 21.6 | 2025-01-08 | 21.6 |
2025-03-14 | 21.6 | 2025-01-07 | 21.6 |
2025-03-13 | 21.6 | 2025-01-06 | 21.6 |
2025-03-12 | 21.6 | 2025-01-03 | 21.6 |
2025-03-11 | 21.6 | 2025-01-02 | 21.6 |
2025-03-10 | 21.6 | 2024-12-31 | 21.6 |
2025-03-07 | 21.6 | 2024-12-30 | 21.6 |
2025-03-06 | 21.6 | 2024-12-27 | 27.6 |
2025-03-05 | 21.6 | 2024-12-26 | 27.6 |
2025-03-04 | 21.6 | 2024-12-24 | 27.6 |
2025-03-03 | 21.6 | 2024-12-23 | 27.6 |
2025-02-28 | 21.6 | 2024-12-20 | 27.6 |
2025-02-27 | 21.6 | 2024-12-19 | 27.6 |
2025-02-26 | 21.6 | 2024-12-18 | 27.6 |
2025-02-25 | 21.6 | 2024-12-17 | 27.6 |
2025-02-24 | 21.6 | 2024-12-16 | 27.6 |
Medacta Group SA (MEDGF) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description

Medacta Group SA
ISIN : CH0468525222
Share Class Description:
MEDGF: Ordinary SharesDescription
Medacta Group SA is involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions.